Bill & Melinda Gates Foundation and Bayer to develop non-hormonal contraception
The affluent foundation and pharmaceutical company will fund preclinical research for four years into new contraceptive options for women, with the hope of finding a development candidate.
by andreas lønstrup, translated by daniel pedersen
Bayer has received a grant from the Bill & Melinda Gates Foundation, establishing a research partnership under which each party commits USD 12m to research on non-hormonal contraception for women, the German pharmaceutical company announces in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
